ROSWELL, Ga., CorMatrix Cardiovascular, Inc., a leading developer of biomaterials and medical devices, today announced treatment of the first patient to receive their tissue engineered regenerative ...

CorMatrix® Cardiovascular, Inc. receives FDA IDE approval to conduct the safety and feasibility clinical trial of the Cor™ TRICUSPID ECM® valve for pediatric and adult patients ...

Dr. Guy is one of only about a dozen cardiovascular surgeons in the United States who has performed complete tricuspid valve repair procedures using CorMatrix®, an extracellular matrix (ECM ...

At two years, 77.6% of patients in the TEER group were alive and free from the need for tricuspid valve surgery or another valve-repair procedure, compared with 29.3% of control patients.

ECU Health Medical Center is introducing two state-of-the-art technologies for transcatheter and tricuspid valve replacement, expanding advanced heart care. Officials say these technologies offer ...

BioWorld - Friday, July 5, 2024 See today's BioWorld MedTech Home » Cormatrix moves into regenerative heart valve space with tricuspid first Subscribe to BioWorld™ news services See subscription ...

Cite this: John M. Mandrola. Questions Remain on Tricuspid Repair at Time of Mitral Surgery - Medscape - Nov 13, 2021.

On behalf of the TANDEM II investigators, we look forward to advancing treatment options for patients suffering from tricuspid regurgitation,” said Dr. Thourani, MD, the Bernie Marcus Chairman ...

In this international, multicenter trial, we randomly assigned 400 patients with severe symptomatic tricuspid regurgitation in a 2:1 ratio to undergo either transcatheter tricuspid-valve ...

Contacts CorMatrix Cardiovascular, Inc. Patricia Cuomo, 470-514-4042 Director, Marketing [email protected] ...